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Abstract 
Background: Methicillin-resistant Staphylococcus aureus (MRSA)-specific hospital discharge 
codes were introduced in October 2008. The purpose of this project is to study the correlation of 
these codes with laboratory-proven pediatric MRSA bloodstream infections. 
Methods: Laboratory and discharge databases were used to identify patients <20 years old 
hospitalized at Cincinnati Children’s Hospital Medical Center from October 2008 through 
December 2010 with MRSA bloodstream infections. The laboratory database identified patients 
with a positive blood culture for MRSA, and the discharge database identified patients with an 
MRSA bloodstream discharge code (038.12 for MRSA sepsis or 041.12 for MRSA infection 
with either 790.7 for bacteremia or 771.81 for newborn sepsis or 771.83 for newborn 
bacteremia). The sensitivity and positive predictive value (PPV) of the codes were determined, 
using laboratory-confirmed infection as the gold standard. 
Results: During the 27 month study period, 65 patients with MRSA bloodstream infection were 
identified from laboratory data and 58 patients were identified from administrative data; 36 were 
concordant. The overall sensitivity was 55.4%, and the overall PPV was 62.1%, and neither 
showed a significant trend over time.  The sensitivity varied with the clinical manifestation of the 
bloodstream infection.  Of the 22 patients coded for MRSA bloodstream infection without a 
positive blood culture, almost half (45.4%) had only a localized MRSA infection.  Of the 29 
patients with positive MRSA blood culture but insufficient discharge coding, the majority 
(55.2%) were coded only for MRSA infection without bloodstream involvement. 
Conclusions: Discharge coding for MRSA bloodstream infection was found to be insensitive and 
to have a low PPV. Using these codes alone will lead to an underestimation of pediatric MRSA 
bloodstream infections.  
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Correlation of Discharge Diagnostic Codes with Laboratory-Confirmed Methicillin-
Resistant Staphylococcus aureus Bloodstream Infections at a Large Pediatric Hospital 
Infection with methicillin-resistant Staphylococcus aureus (MRSA) has become an 
increasingly common pediatric condition over the past 10-15 years.  Unfortunately, the overall 
current epidemiology of MRSA invasive disease among pediatric patients has not been well-
studied to date, except for small studies in various geographic locations.  As has been done with 
other conditions, the national epidemiology of invasive pediatric MRSA infections potentially 
could be monitored using readily available, large-scale administrative databases containing 
International Classification of Diseases 9
th
 Revision (ICD-9) hospital discharge codes.  Such 
administrative databases can be attractive for use because of their relative ease of availability and 
because of the large volume of data that is included.  For example, the National Hospital 
Ambulatory Medical Care Survey (NHAMCS), the National Hospital Discharge Survey 
(NHDS), the Kids’ Inpatient Database (KID), and the Pediatric Health Information System 
(PHIS) are large datasets that include ICD-9 codes and have been used to monitor the burden of 
various other medical conditions.  However, the extent to which these data reflect the true 
underlying clinical condition could vary significantly.  Therefore, if administrative data will 
continue to be used more frequently, specifically for further research regarding pediatric MRSA 
infection, then a better understanding of the correlation between discharge diagnosis codes and 
clinical MRSA disease must be elucidated. 
For this culminating experience project, the hypothesis is that ICD-9 hospital discharge 
codes will only moderately correlate with laboratory-proven MRSA bloodstream infections for 
children hospitalized at Cincinnati Children’s Hospital Medical Center (CCHMC).  Per US 
Department of Health and Human Services Centers for Medicare and Medicaid Services, 
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hospital discharge codes specific to MRSA only came into effect in October 2008.  Prior to this 
time, MRSA infections required at least 2 separate codes to adequately document the infection.  
Some adult studies done at that time already showed a relatively low sensitivity and positive 
predictive value for code combinations in capturing MRSA hospitalizations.  Therefore, for this 
culminating experience, the project will only focus on hospitalizations after October 2008.  The 
discharge code information will be obtained from the CCHMC Finance and Health Information 
Management Department (discharge database), and the MRSA blood culture information will be 
obtained from the CCHMC Infection Control Program (lab database).  These two databases will 
be compared in order to determine the sensitivity and positive predictive value of the ICD-9 
codes for pediatric MRSA bloodstream infections. 
This project was approved by the Institutional Review Board at CCHMC, as part of a 
larger project assessing the overall burden of Staphylococcus aureus disease. 
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Statement of Purpose 
The purpose of this project is to better understand the applicability of administrative 
hospital discharge data for monitoring the epidemiology of pediatric MRSA bloodstream 
infections.  The research hypothesis is that ICD-9 hospital discharge codes specific to MRSA 
bloodstream infection (038.12 for MRSA sepsis or 041.12 for MRSA infection with either 790.7 
for bacteremia or 771.81 for newborn sepsis or 771.83 for newborn bacteremia) will only 
moderately correlate with laboratory-confirmed MRSA bloodstream infections among patients 
less than 20 years old hospitalized at CCHMC during Oct. 2008 – Dec. 2010.  The extent of this 
correlation will be based upon measurement of the sensitivity and positive predictive value of the 
codes.  Further, any discordance between the administrative data and laboratory data will be 
assessed through chart review in order to identify reasons for incomplete correlation.  This 
information is important in order to estimate the burden of and monitor trends for pediatric 
MRSA bloodstream infections in the future. 
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Review of Literature 
Staphylococcus aureus (S. aureus) is a bacterium that commonly colonizes the nasal 
mucosa and skin of humans, but it can cause serious invasive disease when it breaches these 
outermost defenses.  When S. aureus bypasses the skin or mucosal barriers and gains access to 
the deeper tissues and bloodstream, it can cause a wide spectrum of disease.  Most commonly, S. 
aureus infection manifests as skin and soft tissue infection, but it can also cause pneumonia, 
bone and joint infection, bloodstream and cardiac infection, and disseminated disease, among 
others (Gorwitz, 2008).  The factors that determine whether S. aureus causes localized disease or 
more systemic illness are not well-defined but are thought to involve the interplay between the 
host’s defense mechanisms and a myriad of bacterial factors.  For example, it is known that 
individuals with indwelling medical devices, type I diabetes, intravenous drug users, 
hemodialysis or surgical patients, and those with the acquired immunodeficiency syndrome are 
at higher risk for staphylococcal infection (Lowy, 1998).  On the other hand, S. aureus itself can 
produce different virulence factors and can have different antibiotic resistance patterns, resulting 
in various isolates that may be associated with different clinical disease states (David & Daum, 
2010).  Most prominent among these various isolates is methicillin-resistant S. aureus (MRSA), 
as opposed to methicillin-sensitive S. aureus (MSSA).  MRSA is simply a type of S. aureus that 
is resistant to many of the antibiotics that could be used to treat MSSA.  It was first described in 
1961 as a pathogen linked to hospital outbreaks of infection, and over the next 20-30 years, it 
became a well-recognized, commonly isolated healthcare-associated bacterium.  The first report 
of MRSA outside of the healthcare setting occurred in 1982.  These first community-associated 
cases were isolated only from patients who were IV drug users, but subsequently, MRSA has 
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become a prevalent problem in the community at large (David & Daum, 2010; Lowell & Daum, 
2008). 
Over the past several decades, the increased prevalence of MRSA in the community has 
led to more healthcare encounters for illnesses consistent with S. aureus infection.  In Emergency 
Departments across the country, it was reported that the number of visits for skin and soft tissue 
infections (many of which are commonly caused by S. aureus) almost tripled between 1993 and 
2005 (Pallin et al., 2008).  This report was based upon data from the National Hospital 
Ambulatory Medical Care Survey (NHAMCS), which is a national survey of hospital emergency 
and outpatient departments that collects administrative data and applies weights based on the 
sampling method in order to allow for national generalizability (Centers for Disease Control and 
Prevention, 2009).  This administrative database does not include any true microbiologic 
information, so the bacterial cause of the skin and soft tissue infections could not be verified as 
S. aureus.  However, with the increase in skin and soft tissue infections being disproportionate to 
the overall increase in ED visits during the study (increased from 1.35% of 89 million visits in 
1993 to 2.98% of 114 million visits in 2005), this denotes a likely true increase in the rate of skin 
and soft tissue infections and a probable increase in the rate of S. aureus infections (Pallin et al., 
2008). 
For patients requiring hospitalization related to S. aureus, the National Hospital 
Discharge Survey (NHDS) was used to assess the number of hospitalizations in 1999-2000 with 
S. aureus discharge codes, and then US Census data was combined with this to estimate the 
prevalence of S. aureus hospitalizations nationwide (Kuehnert et al., 2005).  While this study 
was based upon administrative data, the process of combining national hospital discharge data 
specific to S. aureus with US Census data provided a framework for estimating the burden of S. 
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aureus hospitalizations across the country.  Therefore, this same process was used by later 
researchers to observe further trends in the rates of S. aureus hospitalizations.  In 2007, Klein, 
Smith, and Laxminarayan (2007) reported that the prevalence of S. aureus attributable 
hospitalizations increased by 62%, from 294,570 to 477,927 hospitalizations from 1999 to 2005.  
Because discharge data did not include reliable differentiation between MRSA and MSSA until 
new codes were introduced in 2008, these studies could not directly assess the proportion of 
MRSA present.  To get around this difficulty, the prevalence of MRSA hospitalization was 
estimated from the numbers of resistant isolates in a national lab surveillance network and then 
extrapolated to the numbers in the discharge databases.  By this process, the prevalence of 
MRSA hospitalizations increased by 119% between 1999 and 2005, from 127,036 
hospitalizations to 278,203 hospitalizations (Klein, Smith, & Laxminarayan, 2007). 
These national studies described amounts of S. aureus disease based upon estimates from 
administrative databases, but they also substantiated several smaller studies based upon 
laboratory defined S. aureus disease.  In 2001 – 2002, Fridkin et al. (2005) performed 
prospective laboratory-based surveillance of culture-proven MRSA disease from clinical labs in 
Baltimore, MD, Atlanta, GE, and Minnesota, with a focus upon community-associated 
infections.  The clinical data submitted with the laboratory samples, such as age, sex, and body 
site of sample collection, allowed the authors to define some of the basic clinical and 
demographic characteristics of patients with MRSA infection.  Only seventeen percent of the 
12,553 MRSA lab cultures in their study were deemed to represent community-associated 
infections and received further analysis (2107 positive cultures).  Of these, they found that the 
annual incidence rate for community-associated MRSA infection was highest among children <2 
years old.  Also, 77% of these community-associated infections manifested as skin and soft 
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tissue infections, and only 6% occurred as invasive infections including bloodstream infection, 
osteomyelitis, or septic arthritis (Fridkin et al., 2005).  Then, in 2004 – 2005, Klevens et al. 
(2007) used the Centers for Disease Control’s Active Bacterial Core (ABC) surveillance program 
to monitor invasive MRSA disease, defined as isolation of MRSA from a normally sterile body 
site.  The ABC program is a laboratory-based system that, in 2005, included 9 US geographic 
areas and represented about 5.6% of the total US population (now includes 10 areas representing 
13.6% of the population) (Centers for Disease Control and Prevention, 2011; U.S. Census 
Bureau, 2011).  In this study, national MRSA incidence rates were calculated by multiplying 
site-specific rates with overall U.S. Census data.  In contrast to Fridkin’s study, the incidence of 
invasive MRSA disease was highest among people >65 years old.  Also, by comparing two of 
the sites used in Fridkin’s study (Atlanta, GA, and Baltimore, MD), Klevens showed large 
increases in the laboratory-proven incidence rates of invasive MRSA disease between 2000 and 
2005 (Atlanta: 19.3  33.0 per 100,000; Baltimore: 40.4  116.7 per 100,000) (Klevens et al., 
2007). 
While some subsets of pediatric patients were included in the national epidemiologic 
studies of S. aureus, relatively few studies have focused specifically upon pediatric populations 
for this disease.  Kaplan et al. (2005) performed a prospective laboratory-based, single-center 
surveillance study in 2001-2004 that looked only at community-associated infections, excluding 
all patients with chronic medical conditions, indwelling vascular access lines, or hospitalizations 
within the preceding year.  During the three year study period, they did see an annual increase in 
the overall number of S. aureus isolates for this population (771 in the first year compared to 
1562 in the third year), with a greater overall increase in MRSA (2.2-fold) compared to MSSA 
(1.7-fold).  The vast majority of both MRSA and MSSA infections were manifest as skin and 
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soft tissue infections (95.6% and 91.8%, respectively) (Kaplan et al., 2005).  Gerber, Coffin, 
Smathers, and Zaoutis (2009) used a national administrative database, the Pediatric Health 
Information System, to assess the incidence and characteristics of S. aureus infections requiring 
hospitalization at any one of thirty-three different free-standing U.S. children’s hospitals between 
2002 and 2007.  All of this data was based upon discharge diagnostic codes, and the distinction 
between MRSA and MSSA was based solely upon the presence or absence of a code denoting 
infection with resistant organisms.  Despite this limitation, during the 6 years of the study, there 
was an overall increase in the incidence of S. aureus infection (20.8  35.8 cases per 1000 
admissions) as well as in increase in the incidence of MRSA infection (6.7  21.2 cases per 
1000 admissions).  Though not all patients had the site of infection noted, of those who did, 61% 
involved the skin and soft tissues.  As noted by the researchers, one of the major limitations of 
this study was that “the accuracy of ICD-9 codes for diagnosis of either S. aureus or MRSA 
infection has not been validated for this large population” (Gerber, Coffin, Smathers, & Zaoutis, 
2009). 
With regard to more invasive disease, the first reports of fatal MRSA infection in 
pediatric patients came from the Minnesota-North Dakota area in 1999.  The report described 
four patients between the ages of 12 months and 13 years who were from various socioeconomic 
and geographic backgrounds and who all succumbed to invasive MRSA infection ("Four 
pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus - 
Minnesota and North Dakota, 1997-1999," 1999).  Other reports of invasive MRSA disease in 
pediatric patients were described in the Houston, TX and Chicago, IL areas in the early 2000’s 
(Gonzalez et al., 2005; Mongkolrattanothai, Boyle, Kahana, & Daum, 2003).  Gonzalez et al. 
(2005) in TX noted an increase in pediatric patients presenting with severe MRSA sepsis from 1 
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case in 1999-2002 to 14 cases in 2002-2004.  Mongkolrattanothai, Boyle, Kahana, and Daum 
(2003) tested several invasive strains of MRSA isolated from pediatric patients in IL and found 
the strains to be genetically similar to MSSA strains that were already prominent in the 
community.  This suggested that the community MRSA isolates may have evolved within the 
previous background of MSSA disease already present (Mongkolrattanothai et al., 2003).  
Looking specifically at bloodstream infections due to MRSA, Carrillo-Marquez, Hulten, Mason, 
and Kaplan (2010) retrospectively analyzed laboratory-based, single-center pediatric data 
surveilling for central vascular catheter associated S. aureus infections in 2001-2007.  They 
found 124 episodes of S. aureus isolates causing bacteremia in 112 children.  Of these, MRSA 
isolates comprised only 25.9% of all of the S. aureus infections (Carrillo-Marquez, Hulten, 
Mason, & Kaplan, 2010). 
Given this relative lack of national epidemiologic information regarding pediatric S. 
aureus disease along with the overall increased incidence of MRSA infection in general, further 
studies assessing pediatric S. aureus epidemiology are warranted.  However, since laboratory and 
clinical-based epidemiologic studies can be very complex and only representative of the local 
population, the use of larger administrative databases including discharge diagnosis data could 
provide a simpler assessment of the disease burden.  This method has been used in several of the 
previously mentioned studies, but the technique requires validation in pediatric S. aureus disease.  
Similar validity tests have already been examined for other types of pediatric infections.  In 
2000-2001, Hsu et al. (2005) tested the validity of rotavirus discharge codes compared to 
laboratory testing in an active surveillance program at one pediatric institution.  This study 
showed that the rotavirus discharge code only had a sensitivity of about 47%, thereby missing 
over half of all laboratory-proven cases (Hsu et al., 2005).  In 2001-2004, Keren et al. (2006) 
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tested the validity of influenza discharge codes compared to all hospitalized patients with 
laboratory confirmed influenza.  Here, the influenza discharge code had a sensitivity of about 
65%, missing 35% of the laboratory-proven cases (Keren et al., 2006).  Clearly, in these other 
infectious processes, the administrative data alone seems to be underrepresentative of the total 
disease burden, to variable extents. 
For S. aureus, and specifically MRSA, no studies have assessed the validity of discharge 
coding to represent clinical disease in pediatric patients.  For adult patients, this has been 
evaluated somewhat, particularly because certain states have passed legislation mandating the 
use of discharge diagnosis codes for reporting healthcare-associated infections including MRSA 
(Schaefer et al., 2010).  At a single adult medical center during 2005-2007, Schaefer et al. (2010) 
correlated MRSA specific discharge diagnostic codes with confirmed MRSA cases.  In this 
study, discharge codes only had a sensitivity of about 59% compared to cases confirmed by lab 
results and chart review, but the codes had a positive predictive value of 93%.  Unfortunately, 
this study was completed prior to the introduction of the new MRSA-specific discharge codes in 
2008, so the applicability of the results to the new codes is unknown (Schaefer et al., 2010). 
Given the ongoing importance of MRSA infection among pediatric populations and the 
need for better epidemiology of the disease in this age group, more studies will likely make use 
of administrative datasets in order to better understand the burden of disease.  Therefore, the 
purpose of this project is to assess the sensitivity and positive predictive value of discharge 
diagnosis codes for MRSA bloodstream infections, so as to better understand the limitations of 
using administrative data to track this disease. 
  




The population of study in this project is all patients less than 20 years old hospitalized at 
Cincinnati Children’s Hospital Medical Center (CCHMC) from October 2008 through December 
2010 with MRSA bloodstream infections.  Bloodstream infections were chosen because this type 
of infection was felt to be the “most clean.”  In other words, from a clinical standpoint, blood 
cultures that grow S. aureus are almost always treated as true infections.  This may not be the 
case for other cultures that grow S. aureus, in which the positive result may be more likely 
interpreted as colonization or contamination.  Therefore, it was thought that bloodstream 
infections would likely have the strongest correlation between administrative and lab data, 
compared to other types of MRSA infection. 
The sampling frames for this population include the database generated by CCHMC 
Infection Control Program (a.k.a. lab database) and the database generated by CCHMC Finance 
and Health Information Management Department (a.k.a. discharge database).  The lab database 
contains all positive blood cultures from the Clinical Laboratory, and the discharge database 
contains all discharge codes for any given hospitalization.  From the lab database, subjects were 
selected if they had a positive blood culture for MRSA; from the discharge database, subjects 
were selected if they had a discharge code indicating MRSA bloodstream infection (038.12 for 
MRSA sepsis or 041.12 for MRSA infection with either 790.7 for bacteremia or 771.81 for 
newborn sepsis or 771.83 for newborn bacteremia).  From these frames, no direct sampling 
method was used, but rather all hospitalizations which met the selection criteria were included.  
Once the hospitalization was identified by either positive blood culture or positive discharge 
code, the corresponding medical record was reviewed.  Through chart review, if the medical 
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providers prescribed treatment (most commonly the use of antimicrobials against MRSA) then 
the hospitalization was counted as having true MRSA infection.  Also through chart review, 
additional clinical information was obtained, including the presence or absence of underlying 
chronic medical disease and the clinical manifestations of the bloodstream infection.  Categories 
were established for both underlying disease and clinical manifestations associated with the 
bloodstream infection.  The estimated incidence of MRSA bloodstream infection at CCHMC is 
approximately 25 hospitalizations per year, resulting in 50 – 75 subjects for this study. 
Measurement 
The primary constructs utilized in this project are MRSA bloodstream infection and 
MRSA discharge diagnostic coding.  To measure MRSA bloodstream infection, the construct 
was operationalized by selecting all positive blood cultures for MRSA from the lab database, 
determining the associated hospitalization, and then reviewing the corresponding medical record 
to assure true MRSA disease.  In this way, the combination of positive blood culture result 
together with clinical information abstracted from the chart review served as the “gold standard” 
for defining MRSA bloodstream infection.  To measure MRSA discharge diagnostic coding, this 
construct was operationalized by selecting all medical records from the discharge database that 
contained certain ICD-9 codes.  In order to determine which ICD-9 codes to use, the goal was to 
include only those codes that would represent MRSA bloodstream infection, excluding other 
MRSA infections that did not involve the bloodstream.  Per the Centers for Medicare & 
Medicaid Services, there are only three codes which indicate MRSA infection in ICD-9.  Those 
are 038.12 for MRSA sepsis, 041.12 for MRSA infection elsewhere, and 482.12 for MRSA 
pneumonia.  Prior to October 2008, MRSA infection had to be coded by using a S. aureus code 
in combination with an antibiotic resistance code, but this need has now been obviated by the 
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introduction of the MRSA-specific codes (Centers for Medicare & Medicaid Services, 2011).  
For this study, in order to capture all potential cases of MRSA bloodstream infection, 038.12 was 
selected along with the combinations of 041.12 with 790.7 for bacteremia or 041.12 with 771.81 
for newborn sepsis or 041.12 with 771.83 for newborn bacteremia.  The only other MRSA 
specific code, 482.42 for MRSA pneumonia, would still require an additional MRSA sepsis or 
MRSA infection with bacteremia code if the patient’s pneumonia was accompanied by 
bloodstream involvement (personal communication with CCHMC Health Information 
Management coding specialist, July 13, 2011).  Thus, the aforementioned codes should capture 
all instances of MRSA bloodstream infection. 
The secondary constructs for this project include chronic underlying disease and clinical 
manifestations of MRSA bloodstream infection.  To measure these, the constructs were 
operationalized by denoting specific categories for each on medical record review.  Chronic 
underlying disease was categorized as the presence or absence of any of the following 
conditions: cancer, chronic otitis media, chronic skin disease, diabetes mellitus, genetic / 
metabolic disorder, immune deficiency, lung disease, neurologic disease, prematurity ≤ 36 weeks 
gestation, prior transplant, renal disease, liver disease, cardiac disease, hematologic disease, GI 
disease, or “other chronic illness.”  Based upon medical record review, each hospitalization was 
categorized as either having no chronic medical disease or having chronic disease in one of these 
categories.  Similarly, the clinical manifestations of MRSA bloodstream infection were divided 
into the following categories: disseminated disease, primary bacteremia, osteomyelitis, joint / 
bursa infection, pulmonary infection, ear-nose-throat infection, intraabdominal infection, deep 
tissue infection, central nervous system infection, urinary tract infection, or skin / soft tissue 
infection.  Bloodstream infection may occur in the setting of any of these manifestations, and 
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each hospitalization was categorized into one of these groups based upon medical record review.  
For purposes of this project, the groups were established to be mutually exclusive.  So, a 
hospitalization was only assigned to one clinical manifestation group, based upon the primary 
presentation. 
Data Collection and Analysis 
The initial list of positive MRSA blood cultures was generated from the lab database and 
then reviewed to find all associated hospitalizations.  All medical records for these 
hospitalizations were then obtained and reviewed.  Clinical information from the medical record, 
including verification of MRSA infection, presence or absence of chronic disease, and the 
associated clinical manifestation, was recorded on a case report form and entered into an 
electronic management database.  If on chart review, the positive blood culture was found not to 
indicate true infection (e.g.: colonization or contamination), the hospitalization was not included 
in further analysis. 
The list of positive MRSA bloodstream infection discharge codes was generated from the 
discharge database and then reviewed for overlap with the lab database.  For any hospitalizations 
not previously identified, medical records were obtained and reviewed.  In this way, all 
hospitalizations could be categorized as either MRSA bloodstream infection with MRSA 
bloodstream discharge code, or MRSA bloodstream infection without MRSA bloodstream 
discharge code, or MRSA bloodstream discharge code without MRSA bloodstream infection.  
Subsequently, two-by-two tables could be constructed (Table 1) in order to determine the 
sensitivity and the positive predictive value of the MRSA ICD-9 codes. 
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Table 1. Sample two-by-two table 
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Once the two-by-two tables are created, the sensitivity of the ICD-9 code is calculated as 
a/(a+c), and the positive predictive value as a/(a+b).  95% confidence intervals (95% CI) can also 
be calculated for each of these ratios based upon the sample sizes, using the “plus-4 method” for 
sample sizes ≥10 or the Fischer exact test for sample sizes <10 (Gerstman, 2008b).  
Unfortunately, because there is no way to determine the value of box d, this data will not allow 
for determination of specificity or negative predictive value.  In addition to determining the 
overall sensitivity and positive predictive value for all MRSA bloodstream infections, these 
measures are also calculated for each year, for presence or absence of chronic disease, and for 
each different clinical manifestation.  Categorical differences between these groups are then 
assessed using chi-square measurements, with results considered significant at an α level of 0.05 
(Gerstman, 2008a). 
Aside from the quantitative outcomes noted above, a qualitative assessment will be made 
to understand the reasons why some hospitalizations were not congruent in both the lab and 
discharge databases.  This will be done by reviewing the data to see if themes arise that may 
account for why a hospitalization with MRSA bloodstream infection did not have the appropriate 
discharge code or why a hospitalization with MRSA bloodstream discharge codes did not have a 
positive MRSA blood culture in the lab.  If consistent themes become evident for these 
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scenarios, then these may serve as potential starting points for improving the sensitivity and 
positive predictive value of the discharge codes over time. 
Research Ethics 
This project was approved by the CCHMC Institutional Review Board (see Appendix) as 
part of the larger approved study, “Determining the Burden of Staphylococcus aureus Disease in 
the Cincinnati Metropolitan Area.”  The IRB approval number is 2010-1450 and expires on 
4/26/2013. 
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Results 
The total number of hospitalizations at CCHMC identified through the lab database for 
positive MRSA blood culture during October 2008 – December 2010 was 65; the total number of 
hospitalizations identified through the discharge database for positive discharge code indicating 
MRSA bloodstream infection was 58.  Thirty-six were concordant and 51 were discordant, 
resulting in a total of 87 hospitalizations for chart review and analysis.  Among the 65 
hospitalizations identified from the lab database, all positive MRSA blood cultures were deemed 
true infections based upon chart review because the medical providers prescribed treatment in 
every case. 
Two-by-two tables were constructed for total and yearly lab and discharge data (Figure 
1).  The lab data are denoted as positive or negative based upon whether or not there was a 
positive blood culture for MRSA.  The discharge data are denoted as positive or negative based 
upon whether or not one of the four possible ICD-9 discharge codes or code combinations for 
MRSA bloodstream infection was present.  The overall sensitivity was 55.4%, with 95% CI = 
43.3% - 66.8%, and the overall positive predictive value was 62.1%, with 95% CI = 49.2% - 
73.4%.  Of note, there were far fewer cases in 2008 compared to 2009 or 2010 because of the 
limited number of months in 2008 (only October – December due to the timing of introduction of 
MRSA-specific codes).  Of the 36 hospitalizations appropriately coded for MRSA bloodstream 
infection, only one-third (12 cases) were coded using the single MRSA sepsis code of 038.12.  
The other two-thirds used code combinations, including an MRSA infection code, 041.12, 
together with a code indicating bloodstream infection, either 790.7 or 771.81 or 771.83. 
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Figure 1. Total and yearly MRSA sensitivities and positive predictive values 
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Chi-square analysis for trend was performed in order to assess how the yearly 
sensitivities and positive predictive values changed over time.  While the positive predictive 
value did increase each year, from 44.4% in 2008 to 70.4% in 2010, neither the positive 
predictive value nor the sensitivity demonstrated a statistically significant trend over the study 
period (Figure 2). 
Figure 2. Chi-square trend analyses for yearly (a) sensitivities and (b) positive predictive values 
For further analysis of the calculated sensitivity, hospitalizations were subdivided among 
those involving patients with or without chronic medical conditions, and among those involving 
each various clinical manifestation of MRSA bloodstream infection.  The sensitivity of the ICD-
9 codes in each group is shown in Table 2, along with the number of subjects and the 95% 
confidence intervals.  Cases of Primary Bacteremia were also further divided out depending upon 
CORRELATION OF ICD-9 CODES WITH MRSA BLOODSTREAM INFECTION 23 
 
the presence of absence of a central venous catheter (CVC).  As can be seen in Table 2, central 
venous catheters were associated with 73.7% (14 out of 19) of the total cases of MRSA primary 
bacteremia. 
Table 2. Sensitivity, by chronic disease and by primary clinical manifestation of MRSA 
bloodstream infection 
Condition Number Sensitivity 95% CI 
Chronic Disease Present    
 YES 34 61.8% 45.0, 76.1 
 NO 31 48.4% 32.0, 65.1 
Clinical Manifestation    
 Primary Bacteremia 19 78.9% 56.0, 91.9 
  CVC-associated 14 78.6% 51.5, 92.9 
  Not CVC-associated 5 80.0% 28.4, 99.5 
 Osteomyelitis 17 35.3% 17.3, 58.9 
 Disseminated 10 60.0% 31.2, 83.1 
 Skin / Soft Tissue 6 33.3% 4.3, 77.7 
 Joint / Bursa 5 40.0% 5.3, 85.3 
 Pulmonary 5 60.0% 14.7, 94.7 
 ENT 1 100.0% 2.5, 100.0 
 Deep Tissue 1 100.0% 2.5, 100.0 
 CNS 1 0.0% 0.0, 97.5 
 Intraabdominal 0 N/A N/A 
 Urinary Tract 0 N/A N/A 
 
Groups with the largest sample sizes were then selected for further comparison.  
Specifically, chi-square comparisons were made between those with chronic disease vs. those 
without chronic disease and also between those with primary bacteremia vs. those with 
osteomyelitis (Figure 3).  Because of the small number of hospitalizations in all other groups, no 
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other between-group comparisons were made.  There was not a statistically significant difference 
between the sensitivity of the group with chronic disease vs. the group without chronic disease.  
However, there was a significant difference, with p <0.01, between the sensitivity of the primary 
bacteremia group vs. the osteomyelitis group. 
Figure 3. Chi-square analyses of sensitivity between groups, (a) chronic disease vs. no chronic 
disease and (b) primary bacteremia vs. osteomyelitis 
Next, the discordant hospitalizations (those in either the lab database or the discharge 
database, but not both) were qualitatively assessed to determine any underlying themes for why 
they were found in one or the other, but not both databases.  For the hospitalizations from only 
the lab database, there were several reasons why they did not meet ICD-9 discharge coding 
criteria for MRSA bloodstream infection (Table 3).  Most common among these was that an 
MRSA infection code was present, but not a code denoting any bloodstream involvement of the 
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infection.  Of note, five hospitalizations with MRSA bloodstream infection were coded as having 
MSSA bloodstream infection instead. 
Table 3. Reasons for discordance between discharge and lab databases in patients with a 
positive MRSA blood culture 
Reason (total number = 29) Number Percent 
MRSA infection code present, but no bloodstream code 16 55.2% 
MSSA sepsis code or MSSA infection code with bloodstream code 
present, but nothing denoting MRSA infection 
5 17.2% 
Neither MRSA infection code nor bloodstream code present 5 17.2% 
Bloodstream code present, but no MRSA infection code 3 10.4% 
 
For the hospitalizations from only the discharge database, there were also several reasons 
why they did not have any lab blood cultures positive for MRSA (Table 4).  Most common 
among these was that the patient had a localized MRSA infection without bloodstream 
involvement, but a bloodstream infection code was generated for another reason, such as a blood 
culture with a different organism.  Of note, eight hospitalizations involving bloodstream 
infections due to MSSA received hospital discharge codes indicating MRSA bloodstream 
infection instead. 
Table 4. Reasons for discordance between discharge and lab databases in patients without a 
positive MRSA blood culture 
Reason (total number = 22) Number Percent 
Localized MRSA infection without evidence of bloodstream involvement 10 45.4% 
MSSA bloodstream infection, rather than MRSA 8 36.4% 
MRSA colonization only (no treatment provided) 2 9.1% 
Prior hospitalization with MRSA bloodstream infection, but no new 
infection during the current admission 
2 9.1% 
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Discussion 
The results of this study support the research hypothesis that ICD-9 hospital discharge 
codes specific to MRSA bloodstream infection would only moderately correlate with laboratory-
confirmed MRSA bloodstream infection.  In fact, the overall sensitivity and positive predictive 
value of the codes was quite low, at 55.4% and 62.1%, respectively.  This finding implies that if 
administrative data, such as the ICD-9 codes used in this study, were employed to monitor 
MRSA bloodstream infection in pediatric hospitalizations, almost 45% of the total actual MRSA 
bloodstream infections would be missed.  Further, of the hospitalizations identified by the use of 
these codes, almost 40% of them would not even involve an MRSA bloodstream infection at all.  
Clearly, these findings demonstrate the inherent difficulties in using administrative data to define 
particular clinical scenarios. 
Over the time period involved in this study, both the sensitivity and positive predictive 
value increased, but not with a statistically significant trend.  The increase may represent some 
improved familiarity with the new diagnosis codes over time, but the fact that there was no 
significant trend shows the relatively static nature of the underlying reasons for inaccuracy.  For 
example, a major difficulty with both the sensitivity and positive predictive value measurements 
was that two codes, both an etiology and a manifestation code, often had to be present in order to 
meet the ICD-9 coding criteria for this study.  While requiring both codes certainly affected the 
study outcomes (65% of the discordant hospitalizations in Table 3 had one or the other but not 
both), there is no other way to indicate the presence of MRSA bloodstream infection as opposed 
to some other type of MRSA infection.  The MRSA sepsis code, 038.12, can be used as a single 
code to indicate MRSA bloodstream infection, but even among the appropriately coded 
hospitalizations, only one-third utilized this code.  Presumably, the remaining hospitalizations 
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could not use this code because the patients had bacteremia (bloodstream infection) rather than 
true sepsis (bloodstream infection with more severe clinical findings such as low blood pressure).  
Unfortunately, this study was not designed to tease out the clinical differences between 
bacteremia and sepsis, and so the sensitivity of the single code for sepsis vs. the combined codes 
for bacteremia could not be assessed.  Regarding the positive predictive value, the combination 
of codes was also problematic in that many hospitalizations coded for MRSA bloodstream 
infection really only had localized MRSA disease without a bloodstream component (45% of the 
discordant hospitalizations in Table 4).  This finding was due to the presence of a localized 
MRSA infection together with a completely separate bloodstream infection due to a different 
organism, and coding for both conditions.  Because there is no mechanism to link etiology and 
manifestation codes, these hospitalizations were misidentified by the administrative data as 
having MRSA bloodstream infection when they really did not. 
Of note, the current national discharge coding system, ICD-9, will be replaced on 
October 1, 2014 with a new system, ICD-10.  Per the Center for Medicare & Medicaid Services 
website, the new ICD-10 data will include thousands more codes, thus allowing the diagnostic 
codes to more accurately reflect various different clinical scenarios.  Hopefully, this new coding 
system would then allow for better quality assessments by “facilitat[ing] evaluation of medical 
processes and outcomes” (Centers for Medicare & Medicaid Services, 2010).  Unfortunately 
though, in order to evaluate the medical processes and outcomes surrounding MRSA 
bloodstream infection, identification of this clinical entity may still be problematic.  Though 
there will be many more codes within the ICD-10 system, combinations of codes will still be 
required in order to fully describe the etiology and manifestation of infections, including MRSA 
bloodstream infections.  Like the current ICD-9, the only intrinsically combined MRSA codes 
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will be those for sepsis and pneumonia (Centers for Medicare & Medicaid Services, 2012).  
Therefore, it is concerning that the same difficulties with sensitivity and positive predictive value 
that were seen in this study will persist despite the adoption of ICD-10. 
Interestingly, the sensitivity of the discharge codes seemed to vary with the clinical 
manifestation of bloodstream infection.  In this study, the sensitivity of the codes for 
hospitalizations involving MRSA primary bacteremia was 78.9%, while the sensitivity of the 
codes for osteomyelitis-associated MRSA bloodstream infection was only 35.3%.  This 
difference was statistically significant, with a p-value < 0.01.  While the exact reasons are not 
clearly defined, it may be postulated that the relative clinical importance of the bloodstream 
component of infection may be different for these different clinical situations.  For example, if a 
patient is hospitalized because of primary bacteremia, then treating the bloodstream infection is 
the main purpose of the hospitalization.  On the other hand, if a patient is hospitalized because of 
osteomyelitis and the bacteremia is noted incidentally or in support of the osteomyelitis, then 
treating the bone infection remains the main purpose of the hospitalization.  Therefore, the 
physician may be more likely to appropriately document the MRSA bloodstream infection in the 
first scenario compared to the second because it is not as clinically relevant.  Because discharge 
codes are generated by hospital coders based directly upon physician documentation, a 
difference in physician documentation would certainly lead to differences in coding and 
subsequent measurements of code sensitivity.  Unfortunately, in this study, the groups with other 
manifestations of MRSA bloodstream infection were too small to allow for reasonable analysis 
of other between-group differences. 
When comparing the groups with chronic disease vs. those without chronic disease, this 
study was not able to detect a statistically significant difference in sensitivity between them.  
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Before starting this project, the author presumed that the sensitivity of the codes would be higher 
among patients without chronic disease because of the inherent surprise that is usually associated 
with a diagnosis of serious invasive infection in an otherwise healthy individual.  On the contrary 
though, the point estimate for sensitivity among patients without chronic disease was actually 
lower than that for patients with chronic disease.  Because of the limited number of subjects, this 
difference did not reach statistical significance.  More hospitalizations would have to be 
reviewed in order to see if there really is a difference and if so, which group has the higher 
sensitivity.  Further, any difference in sensitivity between these two groups could also be due to 
the underlying differences in sensitivity that were seen with the varied clinical manifestations, as 
discussed previously. 
This study exemplifies many issues encountered in the core areas of public health, 
including epidemiology, biostatistics, environmental health, health economics, health systems, 
and global health.  In terms of epidemiology, the burden of MRSA disease certainly seems to 
have increased over the past 10 years, and better methods should be employed to track this 
illness, as noted in the introduction.  Administrative data are an attractive source for monitoring, 
but significant differences exist between clinical data and their reflection in administrative data.  
These differences were demonstrated clearly in this project by the low sensitivity and positive 
predictive values observed for discharge coding of MRSA bloodstream infection.  In terms of 
biostatistics, the sensitivity and positive predictive value measured in this study are commonly 
used tools for various diagnostic tests in medicine.  However, the closeness of these 
measurements to the truth is based largely upon the sample size from which they are calculated.  
As a result, this study provided samples large enough to generate reasonable sensitivities and 
positive predictive values, but not large enough to allow for many comparisons between groups.  
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Further studies are needed in order to more precisely measure the sensitivity and positive 
predictive value in specific populations, and therefore more accurately generalize these results to 
those groups.  In terms of environmental health, MRSA has become a ubiquitous pathogen, with 
large portions of the population simply colonized with this bacteria (Lowell & Daum, 2008).  
However, MRSA is still often considered a nosocomial pathogen in the hospital environment. 
Further, people who have more healthcare exposures overall are more likely to develop 
nosocomial infections (Lowy, 1998).  In this project, such a predisposition to MRSA 
bloodstream infection was seen in that over three-fourths of the cases of MRSA primary 
bacteremia were associated with an indwelling central venous catheter.  Unfortunately, because 
the total number of hospitalizations involving central venous catheters during the study period is 
unknown, the difference between these two groups cannot really be assessed statistically.  
However, the predominance of central vascular catheter associated infections seen here still 
highlights the vital importance of environmental measures affecting care and maintenance of 
medical devices to prevent infection.  In terms of health economics, many researchers have 
attempted to examine the cost difference between infections with MRSA vs. MSSA.  While it 
may seem that infection with MRSA is more expensive to the total healthcare system because of 
the cost of more potent antibiotics, this presumption has not always been born out in the 
literature.  In fact, depending upon the statistical method used to compare the two types of 
infection, some differences have been seen in overall costs and length of hospitalization while 
others have not (Ben-David, Novikov, & Mermel, 2009; Cosgrove et al., 2005).  This project did 
not focus specifically on the economic impact of MRSA bloodstream infection, but further 
analysis could be performed using this data in conjunction with data on MSSA bacteremia during 
the same time period to determine whether or not there were significant differences in lengths of 
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hospitalization and overall costs.  Determining the proportion of the expenses specifically due to 
the MRSA or MSSA infection though, as opposed to other medical issues that arise during the 
hospitalization, may be much more difficult.  In terms of health care systems, this project 
examined a fundamental part of the link between health care providers and health care payers, 
namely diagnostic codes.  These diagnostic codes are fundamental because they provide a 
dominant portion of the determination of reimbursement for healthcare services.  As medical 
care in this country still largely functions in a fee-for-service modality, the fees generated should 
be proportional to the services provided which, for hospitalizations, are often estimated based 
upon the discharge diagnoses present.  So, in theory, the more accurately the discharge diagnoses 
reflect the underlying clinical situations, the more relevant the fees charged to the payers and the 
more appropriate the reimbursements paid to the hospital and providers.  Lastly, in terms of 
global health, MRSA infection is a problem in patients worldwide, though the extent of the 
disease burden seems to vary geographically.  Per 2008 monitoring data from the European 
Union, the percentage of blood isolates of S. aureus that were methicillin-resistant varied from 
<5% in some countries to >50% in others (Kock et al., 2010).  Data for MRSA infection in 
developing countries is much sparser.  Difficulties that have been cited for developing countries 
include the lack of diagnostic microbiologic laboratories necessary to identify MRSA.  For this 
reason, “almost nothing is known about the emergence and transmission of MRSA in resource-
poor regions of the world” (Nickerson, West, Day, & Peacock, 2009).  However, some emerging 
data from China and India suggests that MRSA may account for a significant portion of S. 
aureus disease in these countries.  Additionally, the ready availability of over-the-counter 
antibiotics in developing countries raises concern for the further emergence of community-
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associated MRSA (Nickerson et al., 2009).  Therefore, better surveillance methods for MRSA 
infection are needed, not only in the United States, but also globally as well. 
This project has several important limitations.  First, the fact that all of the data was 
collected from a single center limits the generalizability of the results.  The concept of proximal 
similarity indicates that results from a study can be generalized to other populations depending 
upon how similar or dissimilar the two groups are.  So, for this project, populations that would be 
more similar include those hospitalizations in a similar geographic area (as the epidemiology of 
MRSA infections may vary from one part of the country to another), those involving tertiary 
free-standing children’s hospitals, and those with a similar process of coders assigning discharge 
codes based upon physician documentation in the medical record (rather than physicians 
assigning the codes themselves).  Additionally, because the incidence of MRSA infection seems 
to be evolving over time, proximal similarity would also indicate applicability of the data to the 
present and near future, but not necessarily to the more distant future.  However, even if all of 
these criteria are met, there still may be some amount of inter-institutional variability in the 
coding sensitivity and positive predictive value.  Therefore, in order to apply the outcomes of 
this study to national administrative datasets, this project would likely need to be repeated at 
other institutions that provide inpatient pediatric care.  Second, the inclusion dates of the 
discharge database and the lab database were not exactly the same.  Initially, hospitalizations 
were identified from the lab database if the admission date of the hospitalization occurred within 
30 days of the date of the positive culture.  Because this method could omit some prolonged 
hospitalizations in which the positive culture did not occur within the first 30 days of admission, 
the database was re-queried without this time limit.  When this was completed, no additional 
hospitalizations were identified.  For the discharge database, the initial query was for 
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hospitalizations that had both admission and discharge dates within the timeframe in question.  
However, this method could have omitted hospitalizations in which the patient was admitted 
before October 1, 2008 or discharged after December 31, 2010.  So, the database was rerun with 
a broader time window, and only 1 additional hospitalization was identified.  Therefore, the date 
ranges used for querying the two databases would need to be considered if repeating this project 
at another institution in order to make sure no hospitalizations were missed.  Third, there is a 
possibility for confounding bias since some patients could be involved in more than one 
hospitalization.  In fact, in this project, there were two patients who were admitted multiple times 
with different episodes of MRSA bloodstream infection.  However, both of these patients had 
hospitalizations separated over considerable time periods, and therefore the patients likely had 
distinct episodes of MRSA bloodstream infection.  Thus, two out of the total 65 hospitalizations 
identified from lab data did not represent the first time the patient had MRSA bacteremia.  These 
hospitalizations did not likely affect the measured sensitivities or positive predictive values 
though, since the coding process should be independent of the patient’s history of prior similar 
infections. 
In summary, this project showed the important finding of low sensitivity and positive 
predictive value of ICD-9 discharge codes for pediatric MRSA bloodstream infections.  By 
qualitative review, a substantial reason for these low measures is the need for multiple codes to 
document etiology and manifestation of infection, and this may not be specifically addressed by 
the new ICD-10 coding system.  In order to generalize these results and apply them to national 
administrative datasets, further validation studies in other pediatric institutions will be required. 
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Appendix B: Tier 1 Core Public Health Competencies Used in CE 
Domain #1: Analytic/Assessment 
Identify the health status of populations and their related determinants of health and illness (e.g., factors 
contributing to health promotion and disease prevention, the quality, availability and use of health services) 
Describe the characteristics of a population-based health problem (e.g., equity, social determinants, 
environment) 
Use variables that measure public health conditions 
Use methods and instruments for collecting valid and reliable quantitative and qualitative data 
Identify sources of public health data and information 
Recognize the integrity and comparability of data 
Identify gaps in data sources 
Adhere to ethical principles in the collection, maintenance, use, and dissemination of data and information 
Describe the public health applications of quantitative and qualitative data 
Collect quantitative and qualitative community data (e.g., risks and benefits to the community, health and 
resource needs) 
Use information technology to collect, store, and retrieve data 
Describe how data are used to address scientific, political, ethical, and social public health issues 
Domain #2: Policy Development and Program Planning 
Gather information relevant to specific public health policy issues 
Gather information that will inform policy decisions (e.g., health, fiscal, administrative, legal, ethical, social, 
political) 
Describe the public health laws and regulations governing public health programs 
Identify mechanisms to monitor and evaluate programs for their effectiveness and quality 
Demonstrate the use of public health informatics practices and procedures (e.g., use of information systems 
infrastructure to improve health outcomes) 
Domain #3: Communication 
Communicate in writing and orally, in person, and through electronic means, with linguistic and cultural 
proficiency 
Solicit community-based input from individuals and organizations 
Convey public health information using a variety of approaches (e.g., social networks, media, blogs) 
Participate in the development of demographic, statistical, programmatic and scientific presentations 
Domain #4: Cultural Competency 
Recognize the role of cultural, social, and behavioral factors in the accessibility, availability, acceptability and 
delivery of public health services 
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Domain #5: Community Dimensions of Practice 
Recognize community linkages and relationships among multiple factors (or determinants) affecting health 
(e.g., The Socio-Ecological Model) 
Identify stakeholders 
Maintain partnerships with key stakeholders 
Describe the role of governmental and non-governmental organizations in the delivery of community health 
services 
Domain #6:Public Health Sciences 
Relate public health science skills to the Core Public Health Functions and Ten Essential Services of Public 
Health 
Identify the basic public health sciences (including, but not limited to biostatistics, epidemiology, environmental 
health sciences, health services administration, and social and behavioral health sciences) 
Describe the scientific evidence related to a public health issue, concern, or, intervention 
Retrieve scientific evidence from a variety of text and electronic sources 
Discuss the limitations of research findings (e.g., limitations of data sources, importance of observations and 
interrelationships) 
Describe the laws, regulations, policies and procedures for the ethical conduct of research (e.g., patient 
confidentiality, human subject processes) 
Domain #7: Financial Planning and Management 
Adhere to the organization’s policies and procedures 
Report program performance 
Apply basic human relations skills to internal collaborations, motivation of colleagues, and resolution of 
conflicts 
Demonstrate public health informatics skills to improve program and business operations (e.g., performance 
management and improvement) 
Domain #8: Leadership and Systems Thinking 
Incorporate ethical standards of practice as the basis of all interactions with organizations, communities, and 
individuals 
Identify internal and external problems that may affect the delivery of Essential Public Health Services 
Use individual, team and organizational learning opportunities for personal and professional development 
Participate in the measuring, reporting and continuous improvement of organizational performance 
Describe the impact of changes in the public health system, and larger social, political, economic environment 
on organizational practices 
 
